Plasma proinflammatory cytokine concentrations, acute physiology and chronic health evaluation (APACHE) III scores and survival in patients in an intensive care unit

被引:105
作者
Friedland, JS
Porter, JC
Daryanani, S
Bland, JM
Screaton, NJ
Vesely, MJJ
Griffin, GE
Bennett, ED
Remick, DG
机构
[1] UNIV LONDON ST GEORGES HOSP, SCH MED, DIV INTENS THERAPY, LONDON SW17 0RE, ENGLAND
[2] UNIV LONDON ST GEORGES HOSP, SCH MED, DIV PUBL HLTH SCI, LONDON SW17 0RE, ENGLAND
[3] UNIV MICHIGAN, SCH MED, DEPT PATHOL, ANN ARBOR, MI USA
基金
英国惠康基金;
关键词
cytokines; prognosis; intensive care; systemic inflammatory response syndrome (SIRS); tumor necrosis factor; interleukin-1; interleukin-6; interleukin-8; critical illness;
D O I
10.1097/00003246-199611000-00003
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To more clearly define the relationships between plasma proinflammatory cytokine concentrations, physiologic disturbance, and survival in severely ill patients. Design: Prospective, longitudinal, cohort analytic study. Setting: Teaching hospital intensive care unit (ICU). Patients: Two hundred fifty one consecutive nonselected patients admitted to the ICU. Interventions: None. Measurements and Main Results: Daily Acute Physiology and Chronic Health Evaluation (APACHE) III scores were calculated from clinical and laboratory data. In concurrent blood samples, plasma concentrations were measured of four proinflammatory cytokines (tumor necrosis factor-[TNF] alpha, interleukin [IL]-1 beta, IL-6, and IL-8), all of which are believed to be of central importance in host proinflammatory and immune responses. Plasma TNF concentrations were increased in 42 patients, plasma IL-1 beta in 15 patients, IL-6 in 194 patients, and IL-8 in 52 patients at presentation. Although admission plasma IL-1 beta, IL-6, and IL-8 concentrations were higher in patients who died in the ICU compared with survivors (n=33; p<.02, p<.01, p<.02, respectively), only admission plasma IL-8 concentrations were higher in patients with a fatal outcome if all in-hospital deaths were considered (n=53; p=.05). APACHE III score was the best predictor of mortality (odds ratio 11.41; p=.003). Detection, but not the absolute level, of TNF bioactivity in plasma was a weak independent predictor of death (odds ratio 3.17; p=.02). There was no relationship between bacteremia or presence of the systemic inflammatory response syndrome and plasma cytokine concentrations. Nineteen patients were in the ICU for >10 days, and of these 19 patients, 16 patients had prolonged increases of plasma cytokines. Two patients with persistently increased plasma TNF concentrations died. Otherwise, persistently increased plasma cytokine concentrations had a variable relation to daily APACHE scores and to mortality. Conclusions: Plasma cytokine concentrations fluctuate in serious illness and have a poor correlation with derangement of whole body physiology in seriously ill patients. Only the presence of bioactive TNF in plasma was an independent predictor of mortality. Daily measurement of plasma proinflammatory cytokine concentrations is unlikely to have clinical application in the ICU setting, except possibly in specific subgroups of patients.
引用
收藏
页码:1775 / 1781
页数:7
相关论文
共 37 条
  • [1] PRODUCTION OF HYBRIDOMA GROWTH-FACTOR BY HUMAN-MONOCYTES
    AARDEN, LA
    DEGROOT, ER
    SCHAAP, OL
    LANSDORP, PM
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1987, 17 (10) : 1411 - 1416
  • [2] BEUTLER B, 1993, CRIT CARE MED, V21, pS423
  • [3] A CRITICAL-EVALUATION OF NEW AGENTS FOR THE TREATMENT OF SEPSIS
    BONE, RC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (12): : 1686 - 1691
  • [4] AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    ABRAMS, JH
    BERNARD, GR
    BIONDI, JW
    CALVIN, JE
    DEMLING, R
    FAHEY, PJ
    FISHER, CJ
    FRANKLIN, C
    GORELICK, KJ
    KELLEY, MA
    MAKI, DG
    MARSHALL, JC
    MERRILL, WW
    PRIBBLE, JP
    RACKOW, EC
    RODELL, TC
    SHEAGREN, JN
    SILVER, M
    SPRUNG, CL
    STRAUBE, RC
    TOBIN, MJ
    TRENHOLME, GM
    WAGNER, DP
    WEBB, CD
    WHERRY, JC
    WIEDEMANN, HP
    WORTEL, CH
    [J]. CRITICAL CARE MEDICINE, 1992, 20 (06) : 864 - 874
  • [5] DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS
    BONE, RC
    BALK, RA
    CERRA, FB
    DELLINGER, RP
    FEIN, AM
    KNAUS, WA
    SCHEIN, RMH
    SIBBALD, WJ
    [J]. CHEST, 1992, 101 (06) : 1644 - 1655
  • [6] PROGNOSTIC VALUES OF TUMOR-NECROSIS-FACTOR CACHECTIN, INTERLEUKIN-1, INTERFERON-ALPHA, AND INTERFERON-GAMMA IN THE SERUM OF PATIENTS WITH SEPTIC SHOCK
    CALANDRA, T
    BAUMGARTNER, JD
    GRAU, GE
    WU, MM
    LAMBERT, PH
    SCHELLEKENS, J
    VERHOEF, J
    GLAUSER, MP
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (05) : 982 - 987
  • [7] PLASMA CYTOKINE AND ENDOTOXIN LEVELS CORRELATE WITH SURVIVAL IN PATIENTS WITH THE SEPSIS SYNDROME
    CASEY, LC
    BALK, RA
    BONE, RC
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 119 (08) : 771 - 778
  • [8] TUMOR NECROSIS FACTOR AND INTERLEUKIN-1 SERUM LEVELS DURING SEVERE SEPSIS IN HUMANS
    DAMAS, P
    REUTER, A
    GYSEN, P
    DEMONTY, J
    LAMY, M
    FRANCHIMONT, P
    [J]. CRITICAL CARE MEDICINE, 1989, 17 (10) : 975 - 978
  • [9] CYTOKINE SERUM LEVEL DURING SEVERE SEPSIS IN HUMAN IL-6 AS A MARKER OF SEVERITY
    DAMAS, P
    LEDOUX, D
    NYS, M
    VRINDTS, Y
    DEGROOTE, D
    FRANCHIMONT, P
    LAMY, M
    [J]. ANNALS OF SURGERY, 1992, 215 (04) : 356 - 362
  • [10] SANDWICH ELISA FOR DETECTION OF PICOGRAM QUANTITIES OF INTERLEUKIN-8
    DEFORGE, LE
    REMICK, DG
    [J]. IMMUNOLOGICAL INVESTIGATIONS, 1991, 20 (01) : 89 - 97